SCM
DCPH

Suvretta Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Suvretta Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-862,126
Closed -$29.3M – 117
2021
Q3 		$29.3M Buy
862,126
+209,491
+32% +$6.69M 0.49% 43
2021
Q2 		$23.9M Buy
652,635
+315,827
+94% +$12.2M 0.36% 57
2021
Q1 		$15.1M Buy
+336,808
New +$15.7M 0.22% 64

Other funds holding DCPH

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Suvretta Capital Management's DCPH Position: Q4 2021 in Review

Suvretta Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 862,126 shares — an estimated $29.3M sold.

Suvretta Capital Management first reported a position in DCPH in Q1 2021 and held it in 3 quarters. The position peaked at $29.3M in Q3 2021. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

  • Suvretta Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Suvretta Capital Management sold 862,126 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $29.3M.
  • Suvretta Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Suvretta Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $29.3M in Q3 2021.
  • 140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Suvretta Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.